Menopausal osteoporosis: screening, prevention and treatment.
Yong EL, Logan S.
Singapore Med J. 2021 Apr;62(4):159-166. doi: 10.11622/smedj.2021036.
Long-Term Treatment of Postmenopausal Osteoporosis.
Brown JP.
Endocrinol Metab (Seoul). 2021 Jun;36(3):544-552. doi: 10.3803/EnM.2021.301. Epub 2021 Jun 22.
Secondary osteoporosis.
Stein E, Shane E.
Endocrinol Metab Clin North Am. 2003 Mar;32(1):115-34, vii. doi: 10.1016/s0889-8529(02)00062-2.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women.
Kanis JA, Cooper C, Rizzoli R, Reginster JY; Scientific Advisory Board of the European Society for Clinical and Economic Aspects of Osteoporosis (ESCEO) and the Committees of Scientific Advisors and National Societies of the International Osteoporosis Foundation (IOF).
Osteoporos Int. 2019 Jan;30(1):3-44. doi: 10.1007/s00198-018-4704-5. Epub 2018 Oct 15.
Fracture risk reduction and safety by osteoporosis treatment compared with placebo or active comparator in postmenopausal women: systematic review, network meta-analysis, and meta-regression analysis of randomised clinical trials.
Händel MN, Cardoso I, von Bülow C, Rohde JF, Ussing A, Nielsen SM, Christensen R, Body JJ, Brandi ML, Diez-Perez A, Hadji P, Javaid MK, Lems WF, Nogues X, Roux C, Minisola S, Kurth A, Thomas T, Prieto-Alhambra D, Ferrari SL, Langdahl B, Abrahamsen B.
BMJ. 2023 May 2;381:e068033. doi: 10.1136/bmj-2021-068033.
Osteoporosis. Definition and clinical presentation.
Glaser DL, Kaplan FS.
Spine (Phila Pa 1976). 1997 Dec 15;22(24 Suppl):12S-16S. doi: 10.1097/00007632-199712151-00003.
Use of bone turnover markers in postmenopausal osteoporosis.
Eastell R, Szulc P.
Lancet Diabetes Endocrinol. 2017 Nov;5(11):908-923. doi: 10.1016/S2213-8587(17)30184-5. Epub 2017 Jul 7.
Immunoporosis: Role of immune system in the pathophysiology of different types of osteoporosis.
Zhang W, Gao R, Rong X, Zhu S, Cui Y, Liu H, Li M.
Front Endocrinol (Lausanne). 2022 Sep 6;13:965258. doi: 10.3389/fendo.2022.965258. eCollection 2022.
Secondary causes of osteoporosis.
Fitzpatrick LA.
Mayo Clin Proc. 2002 May;77(5):453-68. doi: 10.4065/77.5.453.
Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
Kobayakawa T, Miyazaki A, Saito M, Suzuki T, Takahashi J, Nakamura Y.
Sci Rep. 2021 Jun 3;11(1):11801. doi: 10.1038/s41598-021-91248-6.
